Sun Pharmaceutical board to consider ₹15,000 crore NCD issue
pre-market1 source ↓machine-written, see hownot a recommendation
- to consider issuing
- 12 Oct 2023
- worth
- ₹15,000 crore
Sun Pharmaceutical Industries Ltd announced its board will meet on 12 Oct 2023 to consider issuing unsecured, redeemable non-convertible debentures worth up to ₹15,000 crore. The NCDs will be issued via private placement in one or more tranches. This move follows a recent licensing agreement for a cholesterol treatment drug, enhancing its product portfolio.
Not investment advice. For informational purposes only.